Regal Drugs Flashcards

1
Q

Mediator that causes redness, heat, swelling and airway constriction but not chemotaxis.

A

Histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vasodilate, increase vascular permeability and cause pain

A

PGE2 and PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What two things cause bronchoconstriction?

A

PGD2 and thromboxane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes platelet aggregation?

A

TXA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What opposes platelet aggregation?

A

PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Kinins (bradykinin and kallidin) are very strong what?

A

Vasodilator!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which way do antihistamines shift the agonist dose-response curve?

A

Right (competitive antagonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which histamine receptor is responsible for most clinically relevant symptoms like bronchoconstriction, contraction of GI smooth muscle, increased capillary permeability (wheal), pruritis and pain, and release of catecholamines?

A

H1 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe how old antihistamines (classical, first generation antihistamines) work.

A

Block H1, Muscarinic, alpha adrenergic, and serotonin receptors, widely distributed (including CNS), not recognized by p-glycoprotein.

Side effects: Sedation, drying of secretions (due to anticholinergic properties), GI disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name the 2 first gen antihistamines we need to know and when to use them.

A

Diphenydramine (good for sedation) and Chlorpheniramine (suitable for daytime).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How are the newer antihistamines different than the first generation ones?

A

Minimal anticholinergic properties, DO NOT cause sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which newer antihistamines do we need to know?

A

Cetirizine, Fexofenadine, Loratadine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why don’t the newer antihistamines cause sedation?

A

B/c pumped out of CNS as they have a high affinity for p-glycoprotein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why were the new antihistamines created?

A

B/c original had cardiotoxicity with overdosage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which COX is constitutively expressed in most cells, protects gastric mucosa, and is found in platelets?

A

COX-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

COX-2

A

NOT in platelets, induced by serum factors, cytokines, and growth factors!

17
Q

What causes pain?

A

Prostaglandins

18
Q

Which drugs inhibit COX-1 and COX-2? What are their shared therapeutic activities?

A

NSAIDs: ANALGESIA: pain of low to moderate intensity, no addiction, lower maximal effects than opioids, block prostaglandin synthesis, ANTIPYRETICS: reduce body temp, ANTI-INFLAMMATORY-reduce redness, swelling, heat, and pain.

19
Q

Which drugs are NSAIDs?

A
Aspirin (irreversible)
Ibuprofen
Naproxen
Ketorolac (promoted for analgesia)
Ketoprofen 
Indomethacin (most potent, severe frontal headache, blood disorders)
Sulindac
Piroxicam (can cause dose-related GI bleeding)
20
Q

What selective COX-2 Inhibitor is still on the market?

A

Celecoxib

21
Q

What drug is analgesic, antipyretic, NOT anti-inflammatory, and is not an NSAID? (also overdosage can cause serious hepatic injury).

A

Acetaminophen

22
Q

Why is acetaminophen better than NSAIDs for headaches?

A

Because it inhibits COX in the brain but not at sites of inflammation.

23
Q

What is the only drug that irreversibly inhibits COX1 in the platelet (preventing aggregation and TX formation)?

A

Aspirin

24
Q

What are the symptoms and what is the cause of aspirin hypersensitivity?

A

Rhinitis, urticaria, asthma, and laryngeal edema.
Blockade of COX shifts arachidonic acid utilization to the lipoxygenase pathway. The end result is increased leukotriene production and the symptoms of hypersensitivity.

25
Q

Risk with COX-2 inhibitors?

A

Reduction of prostacyclin production by endothelial cells thus a concern for increased risk of thrombotic cardiovascular events

26
Q

LTC4, LTD4, and LTE4 are most effect at causing what?

A

Bronchoconstriction

27
Q

LTB4 is effective at causing what?

A

Chemotaxis of WBCs

28
Q

What drugs are used for the treatment of chronic asthma?

A

Leukotriene inhibitors

29
Q

Tell me about Zileuton:

A

inhibits LOX, thus preventing synthesis of LTB4 as well as peptide-leukotrienes.
Metabolized by CYP 450 (think drug interactions)
Maintenance of Chronic asthma

30
Q

Zafirlukast

A

Leukotriene receptor antagonist (LTD4, Cys LTR1), inhibits a CYP450 isoenzyme and may cause significant drug interactions
Used in asthma

31
Q

Montelukast

A

Leukotriene receptor antagonist (LTD4, Cys LTR1) Prescibed more than Zafirlukast because of once daily administration without restrictions with regard to meals.
Used in asthma

32
Q

Sirolimus

A

Binds FKBP to inhibit mTOR (blocking cell cycle progression from G1 to S).
Used in combination therapy for organ transplant rejection.

33
Q

Mycophenolate Mofetil

A

A metabolite inhibits IMPDH (enzyme in pathway of guanine nucleotide synthesis). B and T cells are highly dependent on this pathway.

34
Q

Difference between dosing strategy for cancer vs. immunosuppression?

A

Immunosuppression: low daily dose. Cancer: Pulses of high dose

35
Q

Anti-thymocyte globulin

A

binds to thymocytes in circulation resulting in lymphopenia and impaired T cell immune response.

36
Q

Muromonab-CD3

A

anti-CD3 antibody that causes TCR to become internalized and no further recognition of antigen can occur!

37
Q

Daclizumab or Basiliximab

A

Anti-IL2R (anti-CD25) antibodies used in organ transplantation. Only binds IL-2R on activated T cells to block IL-2 mediated activation events.